<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Cameroon</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Cameroon.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/cm.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Brucella abortus and public health risk: Prevalence in milk sold at open markets in Cameroon</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014051-dc265741/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014051-dc265741/</guid>
    <pubDate>Mon, 23 Mar 2026 00:00:00 GMT</pubDate>
    <description>The detection of B. abortus in milk sold at open markets, combined with widespread risky practices among merchants (low boiling rates and milk pooling), indicates a pathway for human brucellosis exposure beyond traditional farm and abattoir settings.</description>
    <category>Brucellosis</category>
    <category>Treatment</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Genome characterization of the SARS-CoV-2 omicron in Cameroon</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13029-8-78f0e184/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13029-8-78f0e184/</guid>
    <pubDate>Mon, 16 Mar 2026 00:00:00 GMT</pubDate>
    <description>Persistent genomic surveillance remains essential for spotting novel strains and guiding immunization policy adjustments. The widespread presence of antibody-evasion mutations indicates potential pressures on existing preventive measures.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Genomic epidemiology</category>
    <category>Treatment</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Four-year monitoring of the malaria vector Anopheles funestus in central-west Cameroon reveals an escalation of pyrethroid resistance combined with high malaria transmission</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-12708-w-e9441f08/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-12708-w-e9441f08/</guid>
    <pubDate>Wed, 28 Jan 2026 00:00:00 GMT</pubDate>
    <description>The combination of high Plasmodium infection rates, co-circulation of three malaria parasite species, and intense pyrethroid resistance poses a serious threat to malaria control in the region. The findings support prioritizing deployment of PBO-based nets and organophosphate-based indoor residual spraying, along with continuous surveillance to guide intervention strategies toward malaria elimination.</description>
    <category>Malaria</category>
    <category>Transmission dynamics</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Policy uptake and implementation of the RTS,S/AS01 malaria vaccine in sub-Saharan African countries: status 2 years following the WHO recommendation</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2023-014719-e90724cb/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2023-014719-e90724cb/</guid>
    <pubDate>Tue, 30 Apr 2024 00:00:00 GMT</pubDate>
    <description>Twenty of thirty countries applying for vaccine support received financial approval from the Global Alliance for Vaccines and Immunization as of March 2024, demonstrating widespread interest. However, limited RTS,S/AS01 availability prevents some approved countries from receiving required doses, raising vaccine equity concerns.</description>
    <category>Malaria</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Chikungunya outbreak in Montpellier, France, September to October 2014</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es2015-20-17-21108-1b73c8c1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es2015-20-17-21108-1b73c8c1/</guid>
    <pubDate>Thu, 30 Apr 2015 00:00:00 GMT</pubDate>
    <description>The documented containment efforts demonstrate how integrated surveillance and targeted mosquito management can limit localized transmission, reinforcing the necessity of sustained preparedness in regions with competent vectors.</description>
    <category>Chikungunya</category>
    <category>Dengue</category>
    <category>Malaria</category>
    <category>Surveillance</category>
    <category>Travel medicine</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
